Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 194
Selected: 0
NCT IDTitle
NCT04397679Partial Brain RT, Temozolomide, Chloroquine, and TTF Therapy for the Treatment of Newly Diagnosed Glioblastoma
NCT07928154MyPatientPal+: A Smartphone App and a Provider Dashboard to Manage Patient Care While on Treatment
NCT01246206Tacrolimus and Thymoglobulin, as GvHD Prophylaxis in Patients Undergoing Related Donor HCT
NCT00899665Proteases in Patients With Prostate Cancer That Has Spread to the Bone
NCT05028374COVID-19 VAX Booster Dosing in Patients With Hematologic Malignancies
NCT07042191A Provider Intervention to Reduce Financial Toxicity in Patients With Cancer Through Improved Treatment Cost Discussions
NCT02058706LHRH Analogue Therapy With Enzalutamide or Bicalutamide in Treating Patients With Hormone Sensitive Prostate Cancer
NCT04088786Phase I Trial HIPEC With Nal-irinotecan
NCT03033914A(B)VD Followed by Nivolumab as Frontline Therapy for Higher Risk Patients With Classical Hodgkin Lymphoma (HL)
NCT00002547Chemotherapy and Bone Marrow Transplantation in Treating Patients Acute Myeloid With Leukemia or Myelodysplastic Syndrome
NCT00521261Donor T Cells, Low-Dose Aldesleukin, and Low-Dose GM-CSF After Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
NCT009350903'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer
NCT00003925Combination Chemotherapy In Treating Patients With Advanced Cancer
NCT01812668Cabozantinib-S-Malate in Treating Patients With Hormone-Resistant Metastatic Prostate Cancer
NCT00176813Gemcitabine, Cisplatin, and Celecoxib Treatment of Metastatic Pancreatic Cancer
NCT00559897Zoledronic Acid and Positron Emission Tomography in Treating Patients With Advanced Non-Small Cell Lung Cancer
NCT01958372Radiation Therapy, Chemotherapy, and Soy Isoflavones in Treating Patients With Stage IIIA-IIIB Non-Small Cell Lung Cancer
NCT00897247Biomarkers to Detect Mesothelioma Early in Patients Exposed to Asbestos or Vermiculite
NCT01813370A Registry for Patients Treated on the Clinical Trial TAX 3503
NCT00068653Gefitinib and Celecoxib in Treating Patients With Refractory Non-Small Cell Lung Cancer
NCT00004024Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma
NCT03406858Pembro and HER2Bi-Armed Activated T Cells in Treating Patients With Metastatic Castration Resistant Prostate Cancer
NCT03453489AMT-PET in Monitoring Telotristat Etiprate Treatment in Participants With MetastaticNeuroendocrine Neoplasm
NCT00423826Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease
NCT00002907Bryostatin 1 in Treating Patients With Relapsed Multiple Myeloma
NCT00914147Lung Function Testing in Patients With Locally Advanced or Metastatic Solid Tumors
NCT00016185Flavopiridol and Docetaxel in Treating Patients With Advanced Solid Tumors
NCT00768118A Nutritional Supplement Capsule Containing Curcumin, Green Tea Extract, Polygonum Cuspidatum Extract, and Soybean Extract in Healthy Participants
NCT00903214Riluzole in Women With Stage I, Stage II, or Stage IIIA Breast Cancer
NCT02178163Comprehensive Genomic Analysis in Tissue Samples From Patients With Recurrent or Stage IV Non-small Cell Lung Cancer
NCT00217581Bevacizumab, Oxaliplatin, and Docetaxel in Treating Patients With Locally Advanced Unresectable or Metastatic Stomach or Gastroesophageal Junction Cancer
NCT00938626Treated T Cells Followed by a Stem Cell Transplant in Treating Patients With Multiple Myeloma
NCT03421652Nivolumab and RT in Treating Patients With Localized/Locally Advanced Urothelial Bladder Cancer Ineligible for Chemo
NCT01728259First-line Pomalidomide, Bortezomib, and Dexamethasone For AL Amyloidosis or LCDD
NCT00268255Gefitinib and Radiation Therapy in Treating Patients With Inoperable Stage I or Stage II Non-Small Cell Lung Cancer
NCT02723604Low-Level Laser Therapy for Prevention of Oral Mucositis
NCT01420874Anti-CD3 x Anti-Erbitux® Armed Activated T Cells (Phase Ib) for Gastrointestinal (GI Cancer)
NCT00005027Rebeccamycin Analog in Treating Patients With Advanced Kidney Cancer
NCT00244933Gemcitabine Hydrochloride and Genistein in Treating Women With Stage IV Breast Cancer
NCT00288028Bortezomib in Treating Patients With Multiple Myeloma Who Have Undergone an Autologous Peripheral Blood Stem Cell Transplant
NCT03328091Genetic Counseling Processes and Outcomes Among Males With Prostate Cancer (ProGen)
NCT07436078Culturally Adapting an Intervention to Increase Genetic Testing in African American Cancer Survivors
NCT01270880Hsp90 Inhibitor STA-9090 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy
NCT02037256Bortezomib and Filgrastim to Promote Stem Cell Mobilization in Patients With Non-Hodgkin Lymphoma or Multiple Myeloma
NCT00888654Diindolylmethane in Treating Patients With Stage I or Stage II Prostate Cancer Undergoing Radical Prostatectomy
NCT00120029Peer Counseling for Weight Loss
NCT04055649ONC201 Plus Weekly Paclitaxel in Patients With Platinum Refractory or Resistant Ovarian Cancer
NCT00514215Cryotherapy and GM-CSF in Treating Patients With Lung Metastases or Primary Lung Cancer
NCT00248560Gemcitabine and Docetaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer
NCT02470559Activated T-cell Therapy, Low-Dose Aldesleukin, and Sargramostim in Treating Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer That is Stage III-IV, Refractory, or Recurrent